Ionis Pharmaceuticals Inc banner

Ionis Pharmaceuticals Inc
F:ISI

Watchlist Manager
Ionis Pharmaceuticals Inc Logo
Ionis Pharmaceuticals Inc
F:ISI
Watchlist
Price: 70.3 EUR -0.11% Market Closed
Market Cap: €10.3B

Wall Street
Price Targets

ISI Price Targets Summary
Ionis Pharmaceuticals Inc

Wall Street analysts forecast ISI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ISI is 75.75 EUR with a low forecast of 38.61 EUR and a high forecast of 95.99 EUR.

Lowest
Price Target
38.61 EUR
45% Downside
Average
Price Target
75.75 EUR
8% Upside
Highest
Price Target
95.99 EUR
37% Upside
Ionis Pharmaceuticals Inc Competitors:
Price Targets
INO
Inovio Pharmaceuticals Inc
446% Upside
SSRM
SSR Mining Inc
15% Upside
BIOX
Bioceres Crop Solutions Corp
244% Upside

Revenue
Forecast

16% / Year
Past Growth
27% / Year
Estimated Growth
Estimates Accuracy
5%
Average Beat
16% / Year
Past Growth
27% / Year
Estimated Growth
Estimates Accuracy
5%
Average Beat

For the last 13 years the compound annual growth rate for Ionis Pharmaceuticals Inc's revenue is 16%. The projected CAGR for the next 4 years is 27%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-34%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-34%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ISI's stock price target?
Price Target
75.75 EUR

According to Wall Street analysts, the average 1-year price target for ISI is 75.75 EUR with a low forecast of 38.61 EUR and a high forecast of 95.99 EUR.

What is Ionis Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
27%

For the last 13 years the compound annual growth rate for Ionis Pharmaceuticals Inc's revenue is 16%. The projected CAGR for the next 4 years is 27%.

Back to Top